CD37 and acute myeloid leukemia: We analyzed CD37 expression in different risk groups based on NCCN AML classification (Figure 1F), and found that the CD37 expression is significantly lower in favorable risk group than that of intermediate and poor risk group (intermediate: P=0.002; poor: P=0.000344).